Usefulness of real time PCR to quantify parasite load in serum samples from chronic Chagas disease patients
Open Access
- 12 March 2015
- journal article
- research article
- Published by Springer Nature in Parasites & Vectors
- Vol. 8 (1) , 154
Abstract
Inconclusive results of serological diagnosis in Chagas disease have an important impact on blood banks worldwide, reflecting in the high number of discarded bags or in an increased transmission by blood transfusion. Molecular techniques such as qPCR have been used for diagnosis and to monitor Trypanosoma cruzi load in peripheral blood samples. A promising perspective refers to the possibility of parasite DNA detection in serum, taking advantage in using the same samples collected for serological screening. In order to evaluate the effectiveness of a qPCR strategy for detecting and quantifying T. cruzi DNA in serum, we selected 40 chronic Chagas disease patients presenting different clinical manifestations: Cardiac (23), Digestive (4), Mixed form [cardiodigestive] (7), and asymptomatic (6). Twenty seronegative individuals from non-endemic areas were included as controls. Samples were extracted using QIAamp DNA mini kit (QIAGEN) and qPCR was performed in a multiplex format with TaqMan probes for the nuclear satellite DNA of T. cruzi and for the human RNase P gene. In addition, DNA migration to serum during blood coagulation was assessed using a commercial exogenous control (Exo IPC, Applied Biosystems) in a separate qPCR reaction. The comparative duplex qPCR analysis revealed that, even with an increase in Ct values, it was possible to detect all DNA targets in serum. In addition, the same linearity range for T. cruzi quantification (from 105 to 0.5 par. eq./mL) between serum, blood or culture samples (T. cruzi epimastigotes – Cl Brener strain) was found. When patient samples were evaluated, no significant differences in parasite load between the distinct clinical manifestations were found for both blood and serum samples. Moreover, median values of parasite burden were 1.125 and 1.230 par. eq./mL for serum and blood, respectively. Using serology as gold standard, we found 95% sensitivity for T. cruzi detection in serum and 97.5% for blood, and 100% specificity for both samples. Taken together, our data indicate the potential of using serum samples for molecular diagnosis and parasite load quantification by qPCR, suggesting its use in reference laboratories for the diagnosis of Chagas disease patients.Keywords
This publication has 23 references indexed in Scilit:
- Analytical Performance of a Multiplex Real-Time PCR Assay Using TaqMan Probes for Quantification of Trypanosoma cruzi Satellite DNA in Blood SamplesPLOS Neglected Tropical Diseases, 2013
- Sensitive and Specific Detection of Trypanosoma cruzi DNA in Clinical Specimens Using a Multi-Target Real-Time PCR ApproachPLOS Neglected Tropical Diseases, 2012
- International Study to Evaluate PCR Methods for Detection of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease PatientsPLOS Neglected Tropical Diseases, 2011
- Prevalence, Clinical Staging and Risk for Blood-Borne Transmission of Chagas Disease among Latin American Migrants in Geneva, SwitzerlandPLOS Neglected Tropical Diseases, 2010
- Evaluation of Adult Chronic Chagas' Heart Disease Diagnosis by Molecular and Serological MethodsJournal of Clinical Microbiology, 2009
- An Estimate of the Burden of Chagas Disease in the United StatesClinical Infectious Diseases, 2009
- Accurate Real-Time PCR Strategy for Monitoring Bloodstream Parasitic Loads in Chagas Disease PatientsPLOS Neglected Tropical Diseases, 2009
- Prevalência de infecção chagásica em doadores de sangue no estado de Pernambuco, BrasilRevista Brasileira de Ginecologia e Obstetrícia, 2009
- Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samplesActa Tropica, 2007
- Doença de Chagas e transfusão de sangue no Brasil: vigilância e desafiosRevista Brasileira de Ginecologia e Obstetrícia, 2006